Shire's takeover defense may be own quest for deals, Bloomberg says Shire (SHPG)'s optimum defense against becoming a takeover target may be to go on its own quest for deals now that drugmakers are looking for agreements now more than ever, reported Bloomberg. Shire's potential bid for NPS Pharmaceuticals (NPSP) propelled the firm's shares up 20% last week. Reference Link
News For SHPG;NPSP From The Last 14 Days
Check below for free stories on SHPG;NPSP the last two weeks.